SAN FRANCISCO--(BUSINESS WIRE)--W2O Group, a network of fast-growing, complementary digital, marketing and communications firms, announced today that veteran biopharma executive John H. Johnson and healthcare marketing and communications leader Charlene Prounis have joined its board of directors.
“John and Charlene immediately bring complementary business insights, industry access, network exposure and unmatched expertise that can help us more expeditiously catapult to the next level of client-forward expansion and growth,” said Jim Weiss, founder, CEO and board member of W2O Group. “Both are proven and well-recognized leaders with directly relevant expertise that we can apply to better serve our clients and more precisely tailor and target our offerings and partnerships, particularly in healthcare, which currently makes up 75 percent of our business.”
Johnson has more than three decades of commercial and C-suite experience in the pharma and biotech industries where he has held top executive leadership roles for such industry-leading companies as Johnson & Johnson, Eli Lilly, ImClone, Pfizer and Dendreon. He currently serves on the board of directors of several emerging biopharmaceutical companies and previously served on the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as a member of the Health Section Governing Board of the Biotechnology Innovation Organization (BIO).
“You see the way that social media is shifting the landscape of communications and the resulting need for new thinking, models and approaches. W2O continues to lead the way in this new world with great people – real thought leaders,” said Johnson. “Not only will I be able to give back through my experience, but I will be learning at the same time. It’s a very exciting time to be in this business and, at W2O, it’s growing substantially. It’s just an honor to be part of it by joining W2O Group’s board of directors.”
Prounis has been an outstanding leader and entrepreneur in the healthcare communications and marketing services sector over the last 30 years and is a highly engaged advocate for empowering and celebrating women in the healthcare industry. After spending her formative years at Grey Healthcare Group, she successfully launched and led two successive agencies, Accel and Flashpoint Medica, both of which were ultimately acquired by Omnicom. Over two tenures as president of the Healthcare Businesswomen’s Association (HBA), she created the annual HBA Leadership Conference and established the Rising Stars Awards, which celebrate women in the early-to-mid stage of their careers. She has also served as a member of the board of directors of the Medical Advertising Hall of Fame.
“What interested me in joining W2O Group’s board of directors is the fact that this firm is really in front of the trends in the industry,” said Prounis. “If you think about where the agency world is going, it’s going to take a new convergence -- of analytics, creative, technology, and media. W2O Group does that really well.”
To learn more about the two new Board members, check out their interviews here.
About W2O Group
Founded and led by CEO Jim Weiss in 2001, W2O Group is an independent, fast-growing network of complementary digitally-oriented marketing and communications firms focused on integrated business solutions to drive change and growth through "pragmatic disruption" for the world's leading brands and organizations. W2O Group firms employ proprietary analytics models, methodologies and approaches that uncover key insights leading to precise communications and marketing strategies and engagement to deliver business results. W2O Group’s network includes WCG, Twist Mktg, Pure, Marketeching and Sentient, with a growing footprint of offices in the United States and Europe. For more information, please visit www.w2ogroup.com.
Follow W2O Group on Twitter
Follow W2O Group on LinkedIn
Follow W2O Group on Facebook